Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
Open Access
- 1 November 2005
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 19 (21) , 2631-2642
- https://doi.org/10.1101/gad.346405
Abstract
The formation of intramyocardial blood vessels is critical for normal heart development and tissue repair after infarction. We report here expression of the Wilms' tumor gene-1, Wt1, in coronary vessels, which could contribute to the defective cardiac vascularization in Wt1-/- mice. Furthermore, the high-affinity neurotrophin receptor TrkB, which is expressed in the epicardium and subepicardial blood vessels, was nearly absent from Wt1-deficient hearts. Activation of Wt1 in an inducible cell line significantly enhanced TrkB expression. The promoter of NTRK2, the gene encoding TrkB, was stimulated ∼10-fold by transient cotransfection of a Wt1 expression construct. The critical DNA-binding site for activation of the NTRK2 promoter by Wt1 was delineated by DNase I footprint analysis and electrophoretic mobility shift assay. Transgenic experiments revealed that the identified Wt1 consensus motif in the NTRK2 promoter was necessary to direct expression of a reporter gene to the epicardium and the developing vasculature of embryonic mouse hearts. Finally, mice with a disrupted Ntrk2 gene lacked a significant proportion of their intramyocardial blood vessels. These findings demonstrate that transcriptional activation of the TrkB neurotrophin receptor gene by the Wilms' tumor suppressor Wt1 is a crucial mechanism for normal vascularization of the developing heart.Keywords
This publication has 52 references indexed in Scilit:
- A splice variant of the Wilms' tumour suppressorWt1is required for normal development of the olfactory systemDevelopment, 2005
- The biology of vascular endothelial growth factorsPublished by Oxford University Press (OUP) ,2005
- The Major Podocyte Protein Nephrin Is Transcriptionally Activated by the Wilms’ Tumor Suppressor WT1Journal of the American Society of Nephrology, 2004
- Coronary Vessel DevelopmentTrends in Cardiovascular Medicine, 2004
- The Wilms' tumor suppressorWt1is expressed in the coronary vasculature after myocardial infarctionThe FASEB Journal, 2002
- The Wilms' Tumor Gene Product (WT1) Modulates the Response to 1,25-Dihydroxyvitamin D3 by Induction of the Vitamin D ReceptorPublished by Elsevier ,2001
- The Origin of the Subepicardial Mesenchyme in the Avian Embryo: An Immunohistochemical and Quail–Chick Chimera StudyDevelopmental Biology, 1998
- Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicingCell, 1995
- Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal deathCell, 1993
- WT-1 is required for early kidney developmentCell, 1993